| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-06 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |